FC Rejects Ranbaxy’s Allegation that Astrazeneca’s Patent for Enteric Coating of Omeprazole Is Invalid for Obviousness

READ MORE →

Stay informed. Subscribe to PCK IP’s insights for our latest commentary and updates.